SIC
CVS icon

Samalin Investment Counsel’s CVS Health CVS Stock Holding History

Samalin Investment Counsel’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,008
Closed -$252K – 300
2024
Q3 		$252K Sell
4,008
-1,164
-23% -$67.9K 0.11% 242
2024
Q2 		$305K Sell
5,172
-57
-1% -$3.57K 0.14% 214
2024
Q1 		$417K Sell
5,229
-138
-3% -$10.5K 0.2% 173
2023
Q4 		$424K Sell
5,367
-208
-4% -$14.8K 0.21% 159
2023
Q3 		$389K Buy
5,575
+287
+5% +$20.3K 0.22% 135
2023
Q2 		$366K Sell
5,288
-254
-5% -$18.1K 0.2% 144
2023
Q1 		$412K Sell
5,542
-318
-5% -$26.7K 0.25% 122
2022
Q4 		$546K Sell
5,860
-208
-3% -$20.1K 0.35% 88
2022
Q3 		$579K Buy
6,068
+335
+6% +$33.2K 0.42% 65
2022
Q2 		$531K Buy
5,733
+17
+0.3% +$1.66K 0.37% 74
2022
Q1 		$579K Sell
5,716
-20
-0.3% -$2.1K 0.35% 80
2021
Q4 		$592K Sell
5,736
-201
-3% -$18.6K 0.36% 80
2021
Q3 		$504K Buy
5,937
+107
+2% +$8.96K 0.33% 98
2021
Q2 		$487K Sell
5,830
-1,005
-15% -$82.3K 0.32% 102
2021
Q1 		$514K Buy
6,835
+255
+4% +$18.6K 0.34% 97
2020
Q4 		$449K Buy
6,580
+288
+5% +$18.7K 0.34% 94
2020
Q3 		$367K Buy
6,292
+386
+7% +$24K 0.33% 100
2020
Q2 		$383K Sell
5,906
-679
-10% -$42.8K 0.4% 73
2020
Q1 		$390K Buy
6,585
+1,667
+34% +$111K 0.52% 60
2019
Q4 		$365K Buy
+4,918
New +$345K 0.31% 89

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Samalin Investment Counsel's CVS Position: Q4 2024 in Review

Samalin Investment Counsel sold out of CVS Health (CVS) in Q4 2024, closing a stake of 4,008 shares — an estimated $252K sold.

Samalin Investment Counsel first reported a position in CVS in Q4 2019 and held it in 20 quarters. The position peaked at $592K in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Samalin Investment Counsel reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Samalin Investment Counsel sold 4,008 CVS Health shares in Q4 2024, an estimated $252K.
  • Samalin Investment Counsel first reported a position in CVS Health in Q4 2019 and held it in 20 quarters.
  • Samalin Investment Counsel's CVS Health position peaked at $592K in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Samalin Investment Counsel's 13F filing for Q4 2024, filed 11 Feb 2025.